Obesity as a cardiovascular risk factor.

Area of Science:

• Endocrinology
• Cardiology
• Public Health

Background:

• Overweight and obesity prevalence is rising, affecting over half of US adults.
• Obesity, particularly central obesity, is a key risk factor for type 2 diabetes mellitus, hypertension, and cardiovascular disease (CVD).
• Obesity and type 2 diabetes are closely linked with insulin resistance, a condition that appears to develop early in life.

Purpose of the Study:

• To examine the relationship between obesity, insulin resistance, and cardiovascular disease (CVD).
• To explore the role of adipose tissue-secreted molecules in CVD risk.
• To assess the impact of weight loss and improved insulin sensitivity on CVD risk factors.

Main Methods:

• Review of existing literature on obesity, insulin resistance, and cardiovascular health.
• Analysis of the role of adipose tissue-derived signaling molecules (e.g., adiponectin, resistin, leptin).
• Examination of the effects of weight loss interventions and insulin-sensitizing agents.

Main Results:

• Central obesity is associated with hyperinsulinemia, insulin resistance, dyslipidemia, and pro-inflammatory states.
• Adipose tissue secretes various molecules (adiponectin, resistin, TNF-alpha, IL-6) influencing CVD risk.
• Weight loss improves insulin sensitivity, reduces visceral adipose tissue, and favorably alters lipid profiles (lower triglycerides and LDL, higher HDL).

Conclusions:

• Weight loss and improved insulin sensitivity are crucial for mitigating obesity-related risks of type 2 diabetes and cardiovascular disease.
• Targeting visceral adipose tissue and enhancing insulin sensitivity can lead to significant reductions in CVD risk factors.
• Interventions promoting weight loss and insulin sensitivity hold promise for preventing cardiovascular events.